From: Hypnotics and mortality in an elderly general population: a 12-year prospective study
Cardiovascular disease deaths | Cancer deaths | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No n = 6,311 | Yes N = 385 | Model 1a | Model 2b | No n = 6,174 | Yes N = 522 | Model 1a | Model 2b | |||||||||
Variable | n | % | n | % | HR [95% CI] | P | HR [95% CI] | P | n | % | n | % | HR [95% CI] | P | HR [95% CI] | P |
Hypnotic use | ||||||||||||||||
No | 4,962 | 78.62 | 280 | 72.73 | 1 | 0.02 | 1 | 0.56 | 4,818 | 78.04 | 424 | 81.23 | 1 | 0.38 | 1 | 0.73 |
Yes | 1,349 | 21.38 | 105 | 27.27 | 1.32 [1.04;1.66] | 0.92 [0.71;1.20] | 1,356 | 21.96 | 98 | 18.77 | 0.90 [0.72;1.13] | 0.96 [0.74;1.23] | ||||
Number of hypnotics | ||||||||||||||||
0 | 4,962 | 78.62 | 280 | 72.73 | 1 | 0.03 | 1 | 0.78 | 4,818 | 78.04 | 424 | 81.23 | 1 | 0.67 | 1 | 0.94 |
1 | 1,154 | 18.29 | 88 | 22.86 | 1.26 [0.99;1.61] | 0.94 [0.72;1.23] | 1,157 | 18.74 | 85 | 16.28 | 0.91 [0.72;1.15] | 0.96 [0.74;1.25] | ||||
≥2 | 195 | 3.09 | 17 | 4.42 | 1.69 [1.03;2.76] | 0.83 [0.45;1.52] | 199 | 3.22 | 13 | 2.49 | 0.89 [0.51;1.54] | 0.93 [0.50;1.72] | ||||
BZD | ||||||||||||||||
No | 5,321 | 84.31 | 305 | 79.22 | 1 | 0.004 | 1 | 0.60 | 5,170 | 83.74 | 456 | 87.36 | 1 | 0.27 | 1 | 0.42 |
Yes | 990 | 15.69 | 80 | 20.78 | 1.45 [1.13;1.87] | 1.08 [0.81;1.43] | 1,004 | 16.26 | 66 | 12.64 | 0.86 [0.66;1.12] | 0.89 [0.66;1.19] | ||||
BZD-like compounds | ||||||||||||||||
No | 6,008 | 95.20 | 367 | 95.32 | 1 | 0.65 | 1 | 0.12 | 5,879 | 95.22 | 496 | 95.02 | 1 | 0.78 | 1 | 0.44 |
Yes | 303 | 4.80 | 18 | 4.68 | 0.90 [0.56;1.44] | 0.67 [0.40;1.11] | 295 | 4.78 | 26 | 4.98 | 1.06 [0.71;1.57] | 1.18 [0.77;1.82] | ||||
Miscellaneous medications | ||||||||||||||||
No | 6,123 | 97.02 | 369 | 95.84 | 1 | 0.64 | 1 | 0.43 | 5,986 | 96.95 | 506 | 96.93 | 1 | 0.88 | 1 | 0.95 |
Yes | 188 | 2.98 | 16 | 4.16 | 1.13 [0.68;1.87] | 0.80 [0.45;1.41] | 188 | 3.05 | 16 | 3.07 | 0.96 [0.58;1.59] | 1.02 [0.59;1.74] |